Why the study?
The study evaluated the practical efficacy, safety, and long-term adherence to a fixed-dose combination of ramipril/indapamide in patients with grade 1-2 hypertension without blood pressure control or prior therapy.
Does a fixed-dose combination of ramipril/indapamide reduce blood pressure in patients with grade 1-2 hypertension?
Does a fixed-dose combination of ramipril/indapamide reduce blood pressure in patients with grade 1-2 hypertension?
Answers are grounded in this paper and cite their sources.
A fixed-dose combination of ramipril and indapamide effectively reduces blood pressure in patients with grade 1-2 hypertension in a real-world observational setting.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Конради et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: